Clinical and descriptive analysis papers and abstracts
Antiretroviral-drug resistance among patients recently infected with HIV
by Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. Published in the New England Journal of Medicine, 2002.
Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression
by Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
. Published in the Journal of Infectious Diseases, 2002.
Molecular epidemiology of HIV-1 transmission: a case study of source partners of individuals with acute retroviral syndrome.
by Truong HHM, Berrey MM, Shea T, Diem K, Corey L
. Published in the Journal of AIDS , 2002.
Treatment of Primary Human Immunodeficiency Virus Type 1 Infection with Potent Antiretroviral Therapy Reduces Frequency of Rapid Progression to AIDS
by M. Michelle Berrey, Timothy Schacker, Ann C. Collier, Theresa Shea, Scott J. Brodie, Douglas Mayers, Robert Coombs, John Krieger, Tae-Wook Chun, Anthony Fauci, Steven G. Self, and Lawrence Corey. Published in the Journal of Infectious Diseases, April 2001.
Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection.
by Schacker T; Little S; Connick E; GebhardK; Zhang ZQ; Krieger J; Pryor J; Havlir D; Wong JK; Richman D; Corey L; Haase AT. Published in the Journal of Infectious Diseases, February 2001.
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine and indinavir during primary HIV-1 infection.
by Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA. Published in the Journal of Infectious Diseases, August 2000.
Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney.
by Vanhems P; Hughes J; Collier AC; Vizzard J; Perrin L; Cooper DA; Hirschel B; Corey L. Published in AIDS, March 2000.
Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy.
by Schacker T; Little S; Connick E; Gebhard-Mitchell K; Zhang ZQ; Krieger J; Pryor J; Havlir D; Wong JK; Richman D; Corey L; Haase AT. Published in the Journal of Infectious Diseases, January 2000.
Antiviral therapy in primary HIV
by L. Corey and M.M. Berry. Published in Advances in Experimental Medicine and Biology , 1999.
Biological and Virologic Characteristics of Primary HIV Infection
by Timothy Schacker, MD; James Hughes, PhD.; Theresa Shea, PAC; Robert Coombs, MD, PhD; and Lawrence Corey, MD. Published in the Annals of Internal Medicine, April 15, 1998.
Cotton-wool spots in primary HIV infection.
by M. Michelle Berrey; Theresa Shea; and Lawrence Corey. Published in the J Acquir Immune Defic Syndr Hum Retrovirol, 1998.
Clinical and Epidemiologic Features of Primary HIV Infection
by Timothy Schacker, M.D.; Ann Collier, M.D.; James Hughes, PhD.; Theresa Shea, PAC; and Lawrence Corey, M.D. Published in the Annals of Internal Medicine, August 15, 1996.
Abstracts
Stekler, J, Maenza J, Stevens C, Holte S, Malhotra U, McElrath J, Corey L, Collier AC. Abacavir Hypersensitivity Reaction (ABC HSR) in Primary HIV Infection [abstract H-168], ICAAC 44, 2004.
Hecht FM, Wang L, Collier AC, Margolick J, Little S, Kilby M, Benson C, Conway B, Daar E, Markowitz M, Holte S. Is HAART for primary/early HIV infection associated with improved outcomes after treatment discontinuation? Abstract 519. 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10-14, 2003.
Little SJ, S Holte, JP Routy, ES Daar, M Markowitz, AC Collier, RA Koup, B Conway, E Connick, MS Saag, A Mwatha, L Corey, PH Keiser, M. Kilby, K Dawson, JM Whitcomb, NS Hellmann, and DD Richman. Antiretroviral resistance and response to initial therapy among recently HIV infected subjects in North America. 5th HIV Drug Resistance Meeting, 2001, submitted.
Little SJ, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Conway B, Saag MS, Connick E, Holte S, Corey L, Keiser PH, Mwatha A, Dawson K, Whitcomb JM, Hellmann NS, Richman DD. Antiretroviral drug susceptibility and response to initial therapy among recently HIV-infected subjects in North America. Eighth Conference on Human Retroviruses and Opportunistic Infections, Chicago, IL, February 4-8, 2001, Abstract 756.
Geise RE, Maenza J, Collier A, Holte S, Stevens C, Hughes D, Corey L. The effect of pre-treatment on success of HAART among patients with primary HIV. Eighth Conference on Human Retroviruses and Opportunistic Infections, Chicago, IL, February 4-8, 2001, Abstract 401.
Geise R, Maenza J, Collier A, Holte S, Stevens C, Hughes D, Corey L. Effects of therapy delay on virologic failure in early HIV. Eighth Conference on Human Retroviruses and Opportunistic Infections, Chicago, IL, February 4-8, 2001, Abstract 400
Little SJ, Routy JP, Collier AC, Daar ES, Koup RA, Conway B, Saag MS, Holte S, Keiser PH, Mwatha A, Dawson K, Whitcomb JM, Hellman NS, Corey L, Richman DD. The spectrum and frequency of reduced antiretroviral drug susceptibility with primary HIV infection in North America. 4th International Workshop on HIV Drug Resistance and Treatment Strategies, Sitges, Spain, June 12-16, 2000, Abstract 172.
Geise R, Maenza J, Collier A, Shea TL, Stevens C, Hughes D, Holte S, Berrey MM, Corey L. Comparison of early therapy versus delayed therapy in patients followed since early HIV infection. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2000
Malhotra U, Dutta S, Holte S, Berrey M, Delpit E, Sette A, Shea T, Corey L, McElrath MJ. Genetic predictors of virologic and immunologic responses in early-treated patients with HIV-1 infection. International AIDS Meeting, Durban, 2000.